Obshchestvo s ogranichennoj otvetstvennostyu "Detstvo"
发明人:
Palchikova Lyubov Albertovna,Пальчикова Любовь Альбертовна,Ivashuta Tatyana Vladimirovna,Ивашута Татьяна Владимировна
申请号：
RU2017134643
公开号：
RU0002666290C1
申请日:
2017.10.03
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to therapy, namely pediatrics, general medical practice, dermatology and immunology, and can be used to treat psoriasis. For this, first, the centers of chronic infection of the ENT organs are sanitized by local cryotherapy. After this, against the background of medical therapy of psoriasis, a general cryotherapy (OCT) is performed in an open loop cryocamera. In this case, the first OCT procedure is carried out at a temperature of -120 °C for a duration of 1–2 minutes. Subsequent OCT procedures are performed with a decrease in the temperature of the internal environment of the cryocamera to -150…-190 °C with an increase in the duration of the procedure up to 3 minutes. OCT rate is 14–20 daily procedures. In addition, after 5–10 minutes after the patient exits the cryocamera cryodestruction of psoriatic plaques is performed by local contact cryotherapy at a temperature of -140 °C to -170 °C and exposure time 1–2 minutes per 1 dm2 the affected area of the skin to the stage of the white ischemic spot. After completion of OCT, contact cryotherapy treatment is continued until the plaques are completely cleansed of flakes and the hyperkeratosis is reduced, and affects the spots of pigmentation that appear at the site of the plaque in psoriasis. In this case, local cryotherapy is performed by a dry air jet at an outlet temperature of -170 °C at a distance of 2–4 cm from the nozzle, processing the selected area of the patients body surface at the rate of 1–2 minutes per 1 dm2 in mode of decreasing the number of procedures – every day until the onset of pigmentation, a day before the appearance of stable pigmentation, 1–2 times a week until the skin is completely cleansed.EFFECT: method ensures reduction of treatment time, stabilization of clinical manifestations of psoriasis, shortening the time to achieve a positive result and lengthening the periods of primary remission, a sharp decrease in the intensity of
